Elite in Nonalcoholic Steatohepatitis (NASH)
Check Vlad Ratziu's experience treating your condition:
About Vlad Ratziu

Vlad Ratziu practices in Paris, France. Ratziu is rated as an Elite expert by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Alcoholic Cirrhosis, and Liver Transplant.

His clinical research consists of co-authoring 261 peer reviewed articles and participating in 13 clinical trials in the past 15 years. In particular, he has co-authored 137 articles and participated in 10 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).

Paris, 75013, FR
Background & Education
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Doxorubicin Transdrug™ to Best Standard of Care in Patients With Advanced Hepatocellular Carcinoma. ReLive Study.
View 11 Less Clinical Trials -

257 Total Publications

From the Editor's Desk...

Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more